XML 51 R22.htm IDEA: XBRL DOCUMENT
v2.4.0.8

Segment Information | 9 Months Ended
--- | ---
Sep. 30, 2014
Segment Information |
Segment Information | 17. Segment Information In 2013, ProElite was considered to be an operating segment pursuant to ASC Topic 280 “Segment Reporting” since each was budgeted separately and tracked separately to provide the chief operating decision maker information to assess and manage ProElite, Stratus White and Hygeia/Canterbury. The Company suspended operations of ProElite effective June 30, 2013. Following the repositioning of the Company as a specialty biopharmaceutical company, the Board of Directors voted to discontinue operations of ProElite effective March 31, 2014. The following segment information is presented to provide a comparison for the three and nine months ended September 30, 2014 and 2013. A summary of results by segments is as follows:
|  | Three Months Ended September 30, 2014 ($000) |  | Three Months Ended September 30, 2013 ($000) |
|  | Bio- Pharma |  | ProElite (Discont.) |  | Other |  | Total |  | Bio- Pharma |  | ProElite (Discont.) |  | Other |  | Total |
Revenues |  | $ | — |  | $ | — |  | $ | — |  | $ | — |  | $ | — |  | $ | — |  | $ | — |  | $ | — |
Cost of sales |  | — |  | — |  | — |  | — |  | — |  | — |  | — |  | — |
Gross margin |  | — |  | — |  | — |  | — |  | — |  | — |  | — |  | — |
Depreciation and amortization |  | 656 |  | — |  | — |  | 656 |  | — |  | — |  | 7 |  | 7 |
Segment profit |  | (656 | ) | — |  | — |  | (656 | ) | — |  | — |  | (7 | ) | (7 | )
Operating expenses |  | 2,942 |  | — |  | — |  | 2,942 |  | — |  | — |  | 1,670 |  | 1,670 |
Other (income)/expenses |  | (149 | ) | — |  | — |  | (149 | ) | — |  | — |  | (49 | ) | (49 | )
Impact of derivative securities |  | — |  | — |  | — |  | — |  | — |  | — |  | — |  | — |
Net income (loss) from continuing ops. |  | (3,449 | ) | — |  | — |  | (3,449 | ) | — |  | — |  | (1,628 | ) | (1,628 | )
Income from discontinued ops. |  | — |  | — |  | — |  | — |  | — |  | 103 |  | — |  | 103 |
Preferred dividends |  | — |  | — |  | — |  | — |  | — |  | — |  | — |  | — |
Net (loss) income attributable to common shareholders |  | $ | (3,449 | ) | $ | — |  | $ | — |  | $ | (3,449 | ) | $ | — |  | $ | 103 |  | $ | (1,628 | ) | $ | (1,525 | )
|  | Nine Months Ended September 30, 2014 ($000) |  | Nine Months Ended September 30, 2013 ($000) |
|  | Bio- Pharma |  | ProElite (Discont.) |  | Other |  | Total |  | Bio- Pharma |  | ProElite (Discont.) |  | Other |  | Total |
Revenues |  | $ | — |  | $ | — |  | $ | — |  | $ | — |  | $ | — |  | $ | — |  | $ | — |  | $ | — |
Cost of sales |  | — |  | — |  | — |  | — |  | — |  | — |  | — |  | — |
Gross margin |  | — |  | — |  | — |  | — |  | — |  | — |  | — |  | — |
Depreciation and amortization |  | 1,744 |  | — |  | — |  | 1,744 |  | — |  | — |  | 24 |  | 24 |
Segment profit |  | (1,744 | ) | — |  | — |  | (1,744 | ) | — |  | — |  | (24 | ) | (24 | )
Operating expenses |  | 7,929 |  | — |  | — |  | 7,929 |  | — |  | — |  | 10,728 |  | 10,728 |
Other (income)/expenses |  | (388 | ) | — |  | — |  | (388 | ) | — |  | — |  | (34 | ) | (34 | )
Impact of derivative securities |  | — |  | — |  | — |  | — |  | — |  | — |  | (9,217 | ) | (9,217 | )
Net income (loss) from continuing ops. |  | (9,285 | ) | — |  | — |  | (9,285 | ) | — |  | — |  | (1,501 | ) | (1,501 | )
Loss from discontinued ops. |  | — |  | — |  | — |  | — |  | — |  | (153 | ) | — |  | (153 | )
Preferred dividends |  | — |  | — |  | — |  | — |  | — |  | — |  | 172 |  | 172 |
Net (loss) attributable to common shareholders |  | $ | (9,285 | ) | $ | — |  | $ | — |  | $ | (9,285 | ) | $ | — |  | $ | (153 | ) | $ | (1,673 | ) | $ | (1,826 | )
Assets at end of period |  | $ | 50,547 |  | $ | — |  | $ | — |  | $ | 50,547 |  | $ | — |  | $ | 230 |  | $ | 3,005 |  | $ | 3,235 |
Liabilities at end of period |  | $ | 7,748 |  | $ | — |  | $ | — |  | $ | 7,748 |  | $ | — |  | $ | 1,417 |  | $ | 8,153 |  | $ | 9,570 |

X
- Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 29 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8864-108599 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8933-108599 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 26 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8844-108599 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 10 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8538-108599 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8380-108599 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 34 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8981-108599 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 35 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8984-108599 Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 41 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9038-108599 Reference 9: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8906-108599 Reference 10: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 42 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9054-108599 Reference 11: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 31 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8924-108599 Reference 12: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 40 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9031-108599 Reference 13: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 33 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8971-108599 Reference 14: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 12 -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8595-108599 + Details
Name: | us-gaap_SegmentReportingDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration